0001140361-21-021772.txt : 20210621 0001140361-21-021772.hdr.sgml : 20210621 20210621180024 ACCESSION NUMBER: 0001140361-21-021772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cherington Charles CENTRAL INDEX KEY: 0001448698 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 211032266 MAIL ADDRESS: STREET 1: ONE BOW STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ALROY INDUSTRIES INC DATE OF NAME CHANGE: 19850411 4 1 form4.xml FORM 4 X0306 4 2021-06-16 0000748592 Brooklyn ImmunoTherapeutics, Inc. BTX 0001448698 Cherington Charles C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220 true true Common Stock 2021-06-16 4 S 0 200000 15.7338 D 6094101 D Common Stock 2021-06-17 4 S 0 198000 15.7435 D 5896101 D Common Stock 2021-06-17 4 S 0 2000 16.2974 D 5894101 D The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.53 to $16.11, inclusive. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $16.24, inclusive. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 through 3 to this Form 4. /s/ Mark L. Johnson, Attorney-in-Fact for Charles Cherington 2021-06-21